Advertisement

Topics

FDA grants orphan status to Acceleron's muscular dystrophy drug

06:42 EDT 13 Jul 2018 | SmartBrief

Acceleron Pharma's midstage ACE-083 was granted orphan drug designation by the FDA.  -More

Original Article: FDA grants orphan status to Acceleron's muscular dystrophy drug

NEXT ARTICLE

More From BioPortfolio on "FDA grants orphan status to Acceleron's muscular dystrophy drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...